Acorda Therapeutics Inc Valeur d'entreprise
Quel est le Valeur d'entreprise de Acorda Therapeutics Inc?
Le Valeur d'entreprise de Acorda Therapeutics Inc est $569.58M
Quelle est la définition de Valeur d'entreprise?
La valeur d'entreprise est une mesure de la valeur marchande totale d'une entreprise. Il correspond à la capitalisation boursière avec la dette, les intérêts minoritaires et les actions privilégiées moins la trésorerie et les équivalents de trésorerie totaux.
It is a sum of claims by all claimants including creditors (secured and unsecured) and shareholders (preferred and common). Enterprise value is one of the fundamental metrics used in business valuation, financial modeling, accounting, portfolio analysis, and risk analysis. Enterprise value is more comprehensive than market capitalization, which only reflects common equity and is considered more representative of a company’s value. Enterprise value reflects the opportunistic nature of business and may change substantially over time because of both external and internal conditions.
Enterprise value can be negative if the company holds abnormally high amounts of cash that is not reflected in the market value of the stock and total capitalization. Cash is subtracted in the calculation because it reduces the net cost to a potential purchaser. The effect applies whether the cash is used to issue dividends or to pay down debt. Value of minority interest is added because it reflects the claim on assets consolidated into the firm in question. Value of associate companies is subtracted because it reflects the claim on assets consolidated into other firms. EV should also include such special components as unfunded pension liabilities, employee stock options, environmental provisions, abandonment provisions, and so on, since they also reflect claims on the company.
Valeur d'entreprise des entreprises dans Health Care secteur sur NASDAQ par rapport à Acorda Therapeutics Inc
Que fait Acorda Therapeutics Inc?
acorda therapeutics is a publicly traded (nasdaq: acor) biotechnology company whose mission is to develop therapies that restore neurological function and improve the lives of people with neurological disorders. we started our company in 1995 as a network of scientists, physicians and business people with a common belief that sharing ideas and information could lead to innovative medical advances for people with neurological disorders. we have since evolved into a commercial-stage biotechnology company, successfully developing and commercializing important therapies that advance the care of people affected by neurological conditions. we achieve our goals by: • investing in research and development • collaborating closely with the patient, medical and scientific communities • retaining employees with compassion and commitment acorda has been voted one of the best companies to work for in new york for the past five years in a row, as a result of our dynamic environment, strong corporate
Entreprises avec valeur d'entreprise similaire à Acorda Therapeutics Inc
- Heidelberger Druckmaschinen AG a Valeur d'entreprise de $567.55M
- IQE Plc a Valeur d'entreprise de $568.18M
- Artemis Gold a Valeur d'entreprise de $568.28M
- Royal Nickel a Valeur d'entreprise de $568.77M
- DCB Bank a Valeur d'entreprise de $568.97M
- Social Capital Hedosophia IV a Valeur d'entreprise de $569.42M
- Acorda Therapeutics Inc a Valeur d'entreprise de $569.58M
- DCB Bank a Valeur d'entreprise de $569.78M
- HeidelbergCement India a Valeur d'entreprise de $569.90M
- Wajax a Valeur d'entreprise de $570.24M
- Hollywood Bowl Plc a Valeur d'entreprise de $571.02M
- Digital Media Solutions a Valeur d'entreprise de $571.18M
- Jamna Auto Industries a Valeur d'entreprise de $571.40M